Topics

FDA rejects Bausch Health, Eton's EM-100 for allergic conjunctivitis http://www.firstwordpharma.com/node/1652789?tsid=28®ion_id=6#axzz5tOBYUG7c …

18:37 EDT 12 Jul 2019 | FirstWord Pharma

FDA rejects Bausch Health, Eton's EM-100 for allergic conjunctivitis http://www.firstwordpharma.com/node/1652789?tsid=28&region_id=6#axzz5tOBYUG7c …

Original Article: FDA rejects Bausch Health, Eton's EM-100 for allergic conjunctivitis http://www.firstwordpharma.com/node/1652789?tsid=28®ion_id=6#axzz5tOBYUG7c …

NEXT ARTICLE

More From BioPortfolio on "FDA rejects Bausch Health, Eton's EM-100 for allergic conjunctivitis http://www.firstwordpharma.com/node/1652789?tsid=28®ion_id=6#axzz5tOBYUG7c …"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...